Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Clinical Trial
Official title:
Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (Covid-19) Status (Positive or Negative) During Hospitalization
The principal aim of this interventional, multicentre study is to compare the impact of a follow-up by monthly telephone dietetic consultations, started 3 months after discharge from hospital, for a period of 3 months, on the energy intake in patients elderly people recently hospitalized for Coronavirus disease 2019 (Covid-19), Coronavirus disease Positive group "Covid (+)", or not, Coronavirus disease Negative group"Covid (-)". The main outcome measure is to compare the total energy intake at 6 months, after 3 months of dietary consultations, between Coronavirus disease Positive group "Covid (+)" and Coronavirus disease negative group "Covid (-)".
This study consists of nutritional monitoring after hospitalization, carried out by dieticians. Consultations are done remotely, by phone only. Eligible subjects are included, either upon discharge from hospital or within 3 months (at the latest) following their hospitalization. 135 subjects will be included, 50% will be included in Coronavirus disease Positive group "Covid (+)" and 50% in the Coronavirus desease negative group "Covid (-)" . The following data will be collected - At Inclusion (D0): Average length of hospital stay, medical diagnoses, severity of hospital stay, autonomy and dependency scores, albumin and body mass index (BMI). - At M3, M4, M5 and M6: Dietary monitoring data, patient's vital status and dependency scores. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04768998 -
Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
|
||
| Terminated |
NCT04642638 -
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
|
Phase 2/Phase 3 | |
| Terminated |
NCT04940871 -
Study to Assess the Efficacy and Safety of Favipiravir-HU
|
Phase 2 | |
| Completed |
NCT04588363 -
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
|
||
| Completed |
NCT05249816 -
Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine
|
Phase 3 | |
| Recruiting |
NCT04863547 -
Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection
|
||
| Terminated |
NCT04389840 -
Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
|
Phase 2/Phase 3 | |
| Completed |
NCT04725084 -
Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome
|
||
| Completed |
NCT04851821 -
The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
|
Phase 1 | |
| Withdrawn |
NCT05545319 -
A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
|
Phase 2 | |
| Terminated |
NCT04391309 -
COVID-19 and Anti-CD14 Treatment Trial
|
Phase 2 | |
| Completed |
NCT04343261 -
Convalescent Plasma in the Treatment of COVID 19
|
Phase 2 |